Encompass Health Corporation

BOVESPA:E2HC34 Stock Report

Market Cap: R$35.0b

Encompass Health Management

Management criteria checks 3/4

Encompass Health's CEO is Mark Tarr, appointed in Dec 2016, has a tenure of 7.17 years. total yearly compensation is $7.74M, comprised of 13.6% salary and 86.4% bonuses, including company stock and options. directly owns 0.47% of the company’s shares, worth R$165.06M. The average tenure of the management team and the board of directors is 10.5 years and 5.1 years respectively.

Key information

Mark Tarr

Chief executive officer

US$7.7m

Total compensation

CEO salary percentage13.6%
CEO tenure7.2yrs
CEO ownership0.5%
Management average tenure10.5yrs
Board average tenure5.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mark Tarr's remuneration changed compared to Encompass Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

US$355m

Jun 30 2023n/an/a

US$334m

Mar 31 2023n/an/a

US$279m

Dec 31 2022US$8mUS$1m

US$255m

Sep 30 2022n/an/a

US$232m

Jun 30 2022n/an/a

US$242m

Mar 31 2022n/an/a

US$253m

Dec 31 2021US$8mUS$1m

US$296m

Sep 30 2021n/an/a

US$316m

Jun 30 2021n/an/a

US$318m

Mar 31 2021n/an/a

US$304m

Dec 31 2020US$7mUS$953k

US$193m

Sep 30 2020n/an/a

US$265m

Jun 30 2020n/an/a

US$285m

Mar 31 2020n/an/a

US$342m

Dec 31 2019US$7mUS$1m

US$358m

Sep 30 2019n/an/a

US$317m

Jun 30 2019n/an/a

US$308m

Mar 31 2019n/an/a

US$309m

Dec 31 2018US$6mUS$963k

US$290m

Sep 30 2018n/an/a

US$339m

Jun 30 2018n/an/a

US$316m

Mar 31 2018n/an/a

US$288m

Dec 31 2017US$5mUS$900k

US$271m

Compensation vs Market: Mark's total compensation ($USD7.74M) is above average for companies of similar size in the BR market ($USD2.94M).

Compensation vs Earnings: Mark's compensation has been consistent with company performance over the past year.


CEO

Mark Tarr (61 yo)

7.2yrs

Tenure

US$7,735,969

Compensation

Mr. Mark J. Tarr serves as Director at Protective Life Corporation since April 04, 2023. He serves as President, Chief Executive Officer and Director of Encompass Health Corp. since December 29, 2016. He s...


Leadership Team

NamePositionTenureCompensationOwnership
Mark Tarr
CEO, President & Director7.2yrsUS$7.74m0.47%
$ 165.1m
Douglas Coltharp
Executive VP & CFO13.8yrsUS$3.33m0.23%
$ 81.0m
Andrew Price
Senior VP & Chief Accounting Officer14.3yrsUS$904.48k0.070%
$ 24.6m
John Darby
Executive VP8yrsUS$1.91m0.070%
$ 24.5m
Elissa Charbonneau
Chief Medical Officer8.6yrsUS$1.11m0.021%
$ 7.3m
Rusty Yeager
Chief Information Officer & Senior VP12.6yrsno datano data
Mark Miller
Senior Vice President of Investor Relations & Strategic Planning2.4yrsno datano data
Dawn Rock
Chief Compliance Officer8.6yrsno datano data
Anthony Hernandez
Chief Human Resources Officer4.1yrsno datano data
Frank Brown
President of Southwest Region12.4yrsno datano data
Jerry Gray
President of West Region12.4yrsno datano data
Peter Mantegazza
President of Northeast Region15.7yrsno datano data

10.5yrs

Average Tenure

59.5yo

Average Age

Experienced Management: E2HC34's management team is seasoned and experienced (10.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mark Tarr
CEO, President & Director7.2yrsUS$7.74m0.47%
$ 165.1m
John Chidsey
Independent Director16.3yrsUS$357.57k0.16%
$ 56.8m
Donald Correll
Independent Chairman of the Board18.7yrsUS$419.76k0.0013%
$ 452.0k
Joan Herman
Independent Director11.1yrsUS$299.14k0.0010%
$ 350.4k
Leslye Katz
Independent Director11.1yrsUS$297.21k0.0010%
$ 350.4k
Nancy Schlichting
Independent Director6.2yrsUS$262.07k0%
$ 0
Gregory Carmichael
Independent Director4.1yrsUS$269.58k0.0018%
$ 641.2k
Patricia Maryland
Independent Director4.1yrsUS$256.50k0%
$ 0
Christopher Reidy
Independent Director2.3yrsUS$252.49k0.0090%
$ 3.2m
Edward Christie
Directorless than a yearno datano data
Terrance Williams
Independent Director4.1yrsUS$266.31k0.00035%
$ 122.6k
Kevin O'Connor
Independent Director1.9yrsUS$241.79k0.0040%
$ 1.4m

5.1yrs

Average Tenure

63.5yo

Average Age

Experienced Board: E2HC34's board of directors are considered experienced (5.1 years average tenure).